Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9777270 | 1.00 | MEN1 (0.48) | MEN1KMT2APOLBTSHRCYP3A4 | |
| SCHEMBL8622831 | 1.00 | MEN1 (0.48) | MEN1KMT2APOLBTSHRCYP3A4 | |
| SCHEMBL20421972 | 1.00 | MEN1 (0.48) | MEN1KMT2APOLBTSHRCYP3A4 | |
| SCHEMBL28135373 | 0.95 | TSHR (0.46) | MEN1KMT2APOLBTSHRCYP3A4 | |
| SCHEMBL42944 | 0.95 | — | — | |
| SCHEMBL472901 | 0.93 | MEN1 (0.50) | MEN1KMT2APOLBTSHRCYP3A4 | |
| Fluoride SCHEMBL28079954 | 0.93 | — | — | |
| SCHEMBL5180832 | 0.91 | MEN1 (0.54) | MEN1KMT2APOLBTSHRCYP3A4 | |
| SCHEMBL9407356 | 0.91 | MEN1 (0.54) | MEN1KMT2APOLBTSHRCYP3A4 | |
| SCHEMBL5180563 | 0.91 | MEN1 (0.54) | MEN1KMT2APOLBTSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798564-A | Photopolymer holographic recording medium, grating, preparation method and equipment thereof | 珠海莫界科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| EP-2723314-B1 | NOVEL THICKENING POLYMER II | BEIERSDORF AG (DE) | 2019-10-02 | — | — | EP | claimed |
| US-9850454-B2 | Thickening polymer | BEIERSDORF AG (DE) | 2017-12-26 | — | — | US | claimed |
| EP-2576643-B1 | THICKENING POLYMER | BEIERSDORF AG (DE) | 2015-03-04 | — | — | EP | claimed |
| US-20140336101-A1 | NOVEL THICKENING POLYMER | BEIERSDORF AG (DE) | 2014-11-13 | — | — | US | claimed |
| US-20140336377-A1 | ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | RAQUALIA PHARMA INC. (JP) | 2014-11-13 | — | — | US | claimed |
| US-5510301-A | MIXTURE OF LEAD-FREE GLASS FRIT PARTICLES IN LACQUER WITH ADDITIVE OF SUBSTITUTED SORBITOL POLYOL ACETAL, FUMED SILICA TREATED WITH DICHLORODIMETHYLSILANE OR TITANIUM ORTHOESTER COMPLEX AND ALKYL ORGANIC PHOSPHATE ESTER | CORNING INCORPORATED | 1996-04-23 | — | — | US | claimed |
| CN-119798564-A | Photopolymer holographic recording medium, grating, preparation method and equipment thereof | 珠海莫界科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| US-10603269-B2 | Cosmetic preparations with a flow point | BEIERSDORF AG (DE) | 2020-03-31 | — | — | US | disclosed |
| CN-104853807-B | Cosmetic preparation with rheological limit | 拜尔斯道夫股份有限公司 | 2018-11-27 | — | — | CN | disclosed |
| US-20180319911-A1 | THICKENED POLYMER | BEIERSDORF AG (DE) | 2018-11-08 | — | — | US | disclosed |
| US-10023668-B2 | Thickened polymer | BEIERSDORF AG (DE) | 2018-07-17 | — | — | US | disclosed |
| US-9850454-B2 | Thickening polymer | BEIERSDORF AG (DE) | 2017-12-26 | — | — | US | disclosed |
| US-20100087568-A1 | AQUEOUS EPOXY RESIN COMPOSITIONS | HUNTSMAN INTENATIONAL LLC (US) | 2010-04-08 | — | — | US | disclosed |
| EP-2118165-A1 | AQUEOUS EPOXY RESIN COMPOSITIONS | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2009-11-18 | — | — | EP | disclosed |
| WO-2009109600-A1 | FOAMED MATERIALS COMPRISING A MATRIX HAVING A HIGH HARDBLOCK CONTENT AND PROCESS FOR PREPARING THEM | HUNTSMAN INTERNATIONAL LLC (US) | 2009-09-11 | — | — | WO | disclosed |
| WO-2008110479-A1 | AQUEOUS EPOXY RESIN COMPOSITIONS | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2008-09-18 | — | — | WO | disclosed |
| US-20080045667-A1 | Process for preparing polyoxyalkylene glycol ethers using block polymers as demulsifiers | CLARIANT INTERNATIONAL LTD. | 2008-02-21 | — | — | US | disclosed |
| US-20080045652-A1 | Process for preparing polyoxyalkylene glycol ethers using alkoxylated oligo- or polyethyleneimines as demulsifiers | CLARIANT INTERNATIONAL LTD. | 2008-02-21 | — | — | US | disclosed |
| US-20080045666-A1 | Process for preparing polyoxyalkylene glycol ethers using alkoxylated alkylphenol-aldehyde resins as demulsifiers | CLARIANT INTERNATIONAL LTD. | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140336377-A1 | ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | SCN2B, SCN1B, SCN2A | MEN1 4237/4885KMT2A 1036/4885POLB 4126/4885 |
| US-20180319911-A1 | THICKENED POLYMER | VCL, VIL1, MACF1 | MEN1 2222/4885KMT2A 3890/4885POLB 1221/4885 |
| US-10023668-B2 | Thickened polymer | VCL, VIL1, MACF1 | MEN1 2911/4885KMT2A 4133/4885POLB 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.